Browsing by Author Prayongratana K.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2008Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: A case report and literature reviewPrayongratana K.; Kulpraneet M.; Panichchob P.; Tantisiriwat W.
2020Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study GroupWudhikarn K.; Bunworasate U.; Julamanee J.; Lekhakula A.; Ekwattanakit S.; Khuhapinant A.; Chuncharunee S.; Niparuck P.; Numbenjapon T.; Prayongratana K.; Kanitsap N.; Wongkhantee S.; Makruasi N.; Wong P.; Norasetthada L.; Nawarawong W.; Sirijerachai C.; Chansung K.; Suwanban T.; Praditsuktavorn P.; Intragumtornchai T.; on behalf of Thai Lymphoma Study Group
2023Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study GroupThanhakun R.; Wudhikarn K.; Bunworasate U.; Rattanathammethee T.; Norasetthada L.; Kanya P.; Chaloemwong J.; Wongkhantee S.; Phiphitaporn P.; Chansung K.; Jit-ueakul D.; Laoruangroj C.; Prayongratana K.; Wong P.; Julamanee J.; Lekhakula A.; Chuncharunee S.; Niparuck P.; Kanitsap N.; Makruasi N.; Suwanban T.; Praditsuktavorn P.; Khuhapinant A.; Intragumtornchai T.; Srinakharinwirot University
2019Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphomaWudhikarn K.; Bunworasate U.; Julamanee J.; Lekhakula A.; Ekwattanakit S.; Khuhapinant A.; Niparuck P.; Chuncharunee S.; Numbenjapon T.; Prayongratana K.; Kanitsap N.; Wongkhantee S.; Makruasri N.; Wong P.; Norasetthada L.; Nawarawong W.; Sirijerachai C.; Chansung K.; Suwanban T.; Praditsuktavorn P.; Intragumtornchai T.; on behalf of Thai Lymphoma Study Group
2020Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study GroupWudhikarn K.; Bunworasate U.; Julamanee J.; Lekhakula A.; Ekwattanakit S.; Khuhapinant A.; Niparuck P.; Chuncharunee S.; Numbenjapon T.; Prayongratana K.; Kanitsap N.; Wongkhantee S.; Makruasi N.; Wong P.; Norasetthada L.; Nawarawong W.; Sirijerachai C.; Chansung K.; Suwanban T.; Praditsuktavorn P.; Intragumtornchai T.; on behalf of Thai Lymphoma Study Group
2008Low cost combination of DCIP and MCV was better than that of DCIP and OF in the screening for hemoglobin EPrayongratana K.; Polprasert C.; Raungrongmorakot K.; Tatone K.; Santiwatanakul S.
2018Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from ThailandIntragumtornchai T.; Bunworasate U.; Wudhikarn K.; Lekhakula A.; Julamanee J.; Chansung K.; Sirijerachai C.; Norasetthada L.; Nawarawong W.; Khuhapinant A.; Siritanaratanakul N.; Numbenjapon T.; Prayongratana K.; Chuncharunee S.; Niparuck P.; Suwanban T.; Kanitsap N.; Wongkhantee S.; Pornvipavee R.; Wong P.; Makruasi N.; Wannakrairot P.; Assanasen T.; Sukpanichnant S.; Boonsakan P.; Kanoksil W.; Ya-in C.; Kayasut K.; Mitranun W.; Warnnissorn N.
2023Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG)Rattanathammethee T.; Norasetthada L.; Bunworasate U.; Wudhikarn K.; Julamanee J.; Noiperm P.; Lanamtieng T.; Phiphitaporn P.; Navinpipat M.; Kanya P.; Jit-ueakul D.; Wongkhantee S.; Suwannathen T.; Chaloemwong J.; Wong P.; Makruasi N.; Khuhapinant A.; Prayongratana K.; Niparuck P.; Kanitsap N.; Suwanban T.; Intragumtornchai T.; Srinakharinwirot University
2017Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registryWudhikarn K.; Bunworasate U.; Julamanee J.; Lekhakula A.; Chuncharunee S.; Niparuck P.; Ekwattanakit S.; Khuhapinant A.; Norasetthada L.; Nawarawong W.; Makruasi N.; Kanitsap N.; Sirijerachai C.; Chansung K.; Wong P.; Numbenjapon T.; Prayongratana K.; Suwanban T.; Wongkhantee S.; Praditsuktavorn P.; Intragumtornchai T.; on behalf of Thai Lymphoma Study Group